Cognitive decline following major surgery is associated with gliosis, &bgr;-amyloid accumulation, and &tgr; phosphorylation in old mice

Objective:Elderly patients undergoing major surgery often develop cognitive dysfunction and the mechanism of this postoperative complication remains elusive. We sought to determine whether postoperative cognitive dysfunction in old mice is associated with the pathogenesis of Alzheimer's disease. Design:Prospective, randomized study. Setting:University teaching hospital-based research laboratory. Subjects:One-hundred and twenty C57BL/6 14-mo-old male mice (weighing 30-40 g). Interventions:Mice received intraperitoneal injections of either vehicle or Celastrol (a potent anti-inflammatory compound) for 3 days before undergoing sham surgery or partial hepatectomy, on the surgery day, and for a further 4 days after surgery. Cognitive function, hippocampal neuroinflammation, and pathologic markers of Alzheimer's disease were assessed 1 day after surgery day 1, 3, or 7. Measurements and Main Results:Cognitive impairment following surgery was associated with the appearance of certain pathologic hallmarks of Alzheimer's disease: microgliosis, astrogliosis, enhanced transcriptional and translational activity of &bgr;-amyloid precursor protein, &bgr;-amyloid production, and &tgr; protein hyperphosphorylation in the hippocampus. Surgery-induced changes in cognitive dysfunction were prevented by the administration of Celastrol as were changes in &bgr;-amyloid and &tgr; processing. Conclusions:These data suggest that surgery can provoke astrogliosis, &bgr;-amyloid accumulation, and &tgr; phosphorylation in old subjects, which is likely to be associated with the cognitive decline seen in postoperative cognitive dysfunction.

[1]  D. Jeoung,et al.  Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model. , 2009, European journal of pharmacology.

[2]  L. Rasmussen,et al.  Long-term Consequences of Postoperative Cognitive Dysfunction , 2009, Anesthesiology.

[3]  R. W. Johnson,et al.  Neuroinflammation and cognitive function in aged mice following minor surgery , 2008, Experimental Gerontology.

[4]  Yong-Ki Park,et al.  Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-κB in LPS-stimulated BV-2 microglial cells , 2007, Experimental & Molecular Medicine.

[5]  D. Butterfield,et al.  Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment , 2007 .

[6]  B. Aggarwal,et al.  Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. , 2007, Blood.

[7]  M. Maze,et al.  Postoperative Impairment of Cognitive Function in Rats: A Possible Role for Cytokine-mediated Inflammation in the Hippocampus , 2007, Anesthesiology.

[8]  R. Tanzi,et al.  The Inhalation Anesthetic Isoflurane Induces a Vicious Cycle of Apoptosis and Amyloid β-Protein Accumulation , 2007, The Journal of Neuroscience.

[9]  Colin L Masters,et al.  Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics , 2006, Journal of neurochemistry.

[10]  M. Beal,et al.  Celastrol Blocks Neuronal Cell Death and Extends Life in Transgenic Mouse Model of Amyotrophic Lateral Sclerosis , 2006, Neurodegenerative Diseases.

[11]  R. Tanzi Tangles and neurodegenerative disease--a surprising twist. , 2005, The New England journal of medicine.

[12]  C. Eckman,et al.  Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention , 2005 .

[13]  M. Higuchi,et al.  Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions. , 2005, Biochimica et biophysica acta.

[14]  M. Beal,et al.  Celastrol protects against MPTP‐ and 3‐nitropropionic acid‐induced neurotoxicity , 2005, Journal of neurochemistry.

[15]  M. MacDonald,et al.  Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation , 2005, BMC Neuroscience.

[16]  M. Eckenhoff,et al.  Inhaled Anesthetic Enhancement of Amyloid-&bgr; Oligomerization and Cytotoxicity , 2004, Anesthesiology.

[17]  M. Otto,et al.  Role of interleukin-1 in prion disease-associated astrocyte activation. , 2004, The American journal of pathology.

[18]  R. Tanzi,et al.  Hypocapnia Induces Caspase-3 Activation and Increases Aβ Production , 2004, Neurodegenerative Diseases.

[19]  Z. Qiu,et al.  [The experimental study on the inhibitory effect of tripterine on airway inflammation in asthmatic mice]. , 2004, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[20]  A. Bekker,et al.  Cognitive function after anaesthesia in the elderly. , 2003, Best practice & research. Clinical anaesthesiology.

[21]  Qian Sun,et al.  Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens. , 2003, Molecular vision.

[22]  M. Puder,et al.  Partial Hepatectomy in the Mouse: Technique and Perioperative Management , 2003, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[23]  P. Kochanek,et al.  Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. , 2002, Journal of neurotrauma.

[24]  P. Lipsky,et al.  Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. , 2002, Arthritis and rheumatism.

[25]  C. Peers,et al.  Hypoxia potentiates exocytosis and Ca2+ channels in PC12 cells via increased amyloid β peptide formation and reactive oxygen species generation , 2002, The Journal of physiology.

[26]  G. Lenzi,et al.  A case-control study on Alzheimer’s disease and exposure to anesthesia , 2002, Neurological Sciences.

[27]  W. White,et al.  Report of the Substudy Assessing the Impact of Neurocognitive Function on Quality of Life 5 Years After Cardiac Surgery , 2001, Stroke.

[28]  A. Allison,et al.  Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[29]  D. Dickson,et al.  Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.

[30]  Erry,et al.  Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. , 2001, The New England journal of medicine.

[31]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[32]  C. Bergeron,et al.  Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer’s Disease* , 1999, The Journal of Biological Chemistry.

[33]  M. A. Colivicchi,et al.  Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease , 1999, Neuroscience.

[34]  M. Mattson,et al.  Amyloid β-peptide induces apoptosis-related events in synapses and dendrites , 1998, Brain Research.

[35]  P. Rabbitt,et al.  Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study , 1998, The Lancet.

[36]  W. Griffin,et al.  Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.

[37]  H. Li,et al.  Effect of tripterine on collagen-induced arthritis in rats. , 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[38]  S. Younkin,et al.  The Alternatively Spliced Kunitz Protease Inhibitor Domain Alters Amyloid β Protein Precursor Processing and Amyloid β Protein Production in Cultured Cells* , 1996, The Journal of Biological Chemistry.

[39]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.

[40]  D. Munoz,et al.  Role of microglia in senile plaque formation , 1995, Neurobiology of Aging.

[41]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Forloni,et al.  Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. , 1993, Neuroreport.

[43]  C. Finch,et al.  Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. , 1990, Science.

[44]  M. Shin,et al.  Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[45]  L. Villa-komaroff,et al.  Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. , 1989, Science.

[46]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[47]  L. Lachman,et al.  Interleukin 1 of the central nervous system is produced by ameboid microglia , 1986, The Journal of experimental medicine.

[48]  D. Butterfield,et al.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. , 2007, Free radical biology & medicine.

[49]  A. Chow,et al.  Induction of heat shock proteins in differentiated human and rodent neurons by celastrol , 2007, Cell stress & chaperones.

[50]  Alexandra Flemming,et al.  Infectious disease: Unravelling SARS lethality , 2005, Nature Reviews Drug Discovery.

[51]  M. A. Colivicchi,et al.  Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. , 1999, Neuroscience.

[52]  M. Mattson,et al.  Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. , 1998, Brain research.

[53]  S. Younkin,et al.  The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells. , 1996, The Journal of biological chemistry.

[54]  N. Bohnen,et al.  Early and midlife exposure to anesthesia and age of onset of Alzheimer's disease. , 1994, The International journal of neuroscience.

[55]  J. Guo,et al.  Tripterygium wilfordii Hook f in rheumatoid arthritis and ankylosing spondylitis. Preliminary report. , 1981, Chinese medical journal.